Reliv International Inc (RELV):企業の財務・戦略的SWOT分析

◆英語タイトル:Reliv International Inc (RELV) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14805
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Reliv International Inc (Reliv) is a nutrition company that develops, manufactures and markets nutritional supplements for basic nutrition, specific wellness needs, weight management and sports nutrition. The company’s products include Reliv Classic and Reliv NOW, a nutritional supplement with a proprietary blend of vitamins and minerals, soy and herbs; Innergize!, an isotonic sports formula for performance enhancement; FibRestore, a high-fiber and antioxidant supplement; and LunaRich X, a soy concentrated form of lunasin in capsule form, and others. It also provides blending, processing, and packaging services for other companies’ food products on a contract basis. The company distributes its products through a network of independent distributors across the US, Australia, Canada, France, Indonesia, Mexico, Malaysia, the Netherlands, New Zealand, Singapore and the UK, among others. Reliv is headquartered in Chesterfield, Missouri, the US.

Reliv International Inc Key Recent Developments

Nov 09,2018: Reliv International reports third-quarter financial results for 2018
Aug 10,2018: Reliv International reports second-quarter financial results for 2018
Jun 06,2018: Reliv International Names Ryan Montgomery Chief Executive Officer
May 11,2018: Reliv International posts financial results for Q1 2018

This comprehensive SWOT profile of Reliv International Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Reliv International Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Reliv International Inc – Key Information
Reliv International Inc – Overview
Reliv International Inc – Key Employees
Reliv International Inc – Key Employee Biographies
Reliv International Inc – Key Operational Heads
Reliv International Inc – Major Products and Services
Reliv International Inc – History
Reliv International Inc – Company Statement
Reliv International Inc – Locations And Subsidiaries
Reliv International Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Reliv International Inc – Business Description
Reliv International Inc – Corporate Strategy
Reliv International Inc – SWOT Analysis
SWOT Analysis – Overview
Reliv International Inc – Strengths
Reliv International Inc – Weaknesses
Reliv International Inc – Opportunities
Reliv International Inc – Threats
Reliv International Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Reliv International Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Reliv International Inc, Key Information
Reliv International Inc, Key Ratios
Reliv International Inc, Share Data
Reliv International Inc, Major Products and Services
Reliv International Inc, History
Reliv International Inc, Key Employees
Reliv International Inc, Key Employee Biographies
Reliv International Inc, Key Operational Heads
Reliv International Inc, Other Locations
Reliv International Inc, Subsidiaries
Reliv International Inc, Key Manufacturing facilities
Reliv International Inc, Key Competitors
Reliv International Inc, SWOT Analysis
Reliv International Inc, Ratios based on current share price
Reliv International Inc, Annual Ratios
Reliv International Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Reliv International Inc, Performance Chart
Reliv International Inc, Ratio Charts

★海外企業調査レポート[Reliv International Inc (RELV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C3J Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary C3J Therapeutics Inc (C3J), formerly C3 Jian Inc, is a clinical-stage biotechnology company which concentrates on the development and commercialization of targeted and pathogen specific, antimicrobials that treat and prevent diseases caused by microbial dysbiosis. Its pipeline product portfo …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Banco BPM S.p.A.:企業の戦略・SWOT・財務分析
    Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Ernst & Young Global Ltd:企業の戦略・SWOT・財務情報
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Capricor Therapeutics Inc (CAPR):製薬・医療:M&Aディール及び事業提携情報
    Summary Capricor Therapeutics Inc (Capricor) is a biotechnology company that discovers, develops and commercializes biological therapeutics for the treatment of rare disorders. The company offers cardiac cell therapy and cenderitide products for the treatment of post myocardial infarction, advanced …
  • Forrester Research, Inc.:企業の戦略・SWOT・財務分析
    Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report Summary Forrester Research, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Eisai Co., Ltd.:企業のM&A・事業提携・投資動向
    Eisai Co., Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eisai Co., Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • KPIT Technologies Ltd (BSOFT):企業の財務・戦略的SWOT分析
    KPIT Technologies Ltd (BSOFT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Accenture Plc (ACN):企業の財務・戦略的SWOT分析
    Accenture Plc (ACN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Expedia Inc:戦略・SWOT・企業財務分析
    Expedia Inc - Strategy, SWOT and Corporate Finance Report Summary Expedia Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Clariant International Ltd (CLN):企業の財務・戦略的SWOT分析
    Clariant International Ltd (CLN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tyson Foods Inc:戦略・SWOT・企業財務分析
    Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • TIE Kinetix N.V. (TIE):企業の財務・戦略的SWOT分析
    TIE Kinetix N.V. (TIE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Amedisys, Inc.:企業の戦略・SWOT・財務分析
    Amedisys, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amedisys, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • QuikTrip Corporation:企業の戦略的SWOT分析
    QuikTrip Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Mayne Pharma Group Ltd (MYX)-製薬・医療分野:企業M&A・提携分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd, a subsidiary of Hospira Inc, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise astrix capsules and tablets, erymax cap …
  • Astrazeneca Pharma India Ltd (ASTRAZEN):企業の財務・戦略的SWOT分析
    Summary AstraZeneca Pharma India Ltd (AstraZeneca), a subsidiary of AstraZeneca Plc, is a biopharmaceutical company. It discovers, develops, supplies and commercializes medicines. The company’s product portfolio include Forxiga, Imdur, Crestor, Tagrisso, Lynparza, Betaloc, Symbicort, budesonide, for …
  • Salter Labs-医療機器分野:企業M&A・提携分析
    Summary Salter Labs (Salter) is a medical device company that offers home, HME and acute care products. The company offers products which include swivel connector, whisper and silhouette cannula, visible tubing, petite cannula sensitive grips, static connector and humidifier tubing. It also offers o …
  • Meta Biomed Co Ltd (059210):企業の製品パイプライン分析2018
    Summary Meta Biomed Co Ltd (Meta Biomed) is a medical device company that develops and manufactures dental materials and equipments. The company provides suture, dental, bone and medical products. It offers various medical products such as endodontic materials, bone restorative materials, implant ma …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆